Raoul E. Benveniste

发表

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

T. Copeland, R. Sowder, L. Henderson, 1988, Science.

Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques.

R. Grant, K. E. Follis, C. Tsai, 1994, The Journal of infectious diseases.

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.

J. Lifson, W. Alvord, L. Arthur, 2004, AIDS Research and Human Retroviruses.

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

J. Lifson, L. Arthur, J. Bess, 1998, AIDS research and human retroviruses.

Protection from pathogenic SIV challenge using multigenic DNA vaccines.

N. Haigwood, D. Montefiori, P. Greenberg, 1999, Immunology letters.

Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

J. Davies, R. Benveniste, Julian Davies, 1971, Biochemistry.

ENZYMES THAT INACTIVATE ANTIBIOTICS IN TRANSIT TO THEIR TARGETS *

J. Davies, R. Benveniste, Julian Davies, 1974, Annals of the New York Academy of Sciences.

R FACTORS: BIOCHEMICAL MECHANISMS OF RESISTANCE TO AMINOGLYCOSIDE ANTIBIOTICS *

M. Brzezinska, J. Davies, R. Benveniste, 1971 .

Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver.

M. Gonda, J. Ward, C. Fox, 1996, The American journal of pathology.

Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.

G. Barber, L. Kuller, R. Benveniste, 1993, Journal of medical primatology.

Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions.

T. Copeland, R. Sowder, L. Henderson, 1990, Journal of medical primatology.